Iodine-131 tositumomab (Bexxar) in a radiation oncology environment.
Related Articles
Iodine-131 tositumomab (Bexxar) in a radiation oncology environment.
Int J Radiat Oncol Biol Phys. 2006;66(2 Suppl):S30-4
Authors: Macklis RM
Iodine-131 (I-131) tositumomab (Bexxar; GlaxoSmithKline, Research Triangle Park, NC) is one of two recently approved radiolabeled antibodies directed against the CD20 surface antigen found on normal B cells and in more than 95% of B cell […]
Filed under: radiation | No Comments »